L9P-29536-89241
3 vaccinations
7 coded responses
17 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body achesAdult check-in
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Injection site mass — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Hard bump at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-01-19
- 2021-01-22
- 2021-01-27
-
2021-02-03
Survey response — day 21, dose 2MedDRA: Rash, Rash pruritic — Feeling: GoodFree text: Continue to have rash on arms that is itchy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-17
-
2021-02-26
Survey response — day 42, dose 2MedDRA: Fatigue, Nasal congestion, Nasopharyngitis, Respiratory tract congestion, Sneezing — Feeling: GoodFree text: Had a cold, sneezing, congestion, stuffy nose, fatigue. No fever or cough.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
-
2021-07-14
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-13
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Dose 3 — Pfizer-BioNTech
-
2022-05-16
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold like symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-08-15
-
2023-02-14
Survey response — 12 months, dose 3MedDRA: Headache, Illness, Nausea, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-14
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-15
-
2023-02-15
Callback requested for10:00AM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2022-02-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Hard bump at injection site.
Release 3 — day 21, dose 2
Symptoms: Continue to have rash on arms that is itchy.
Release 4 — day 42, dose 2
Symptoms: Had a cold, sneezing, congestion, stuffy nose, fatigue. No fever or cough.
Release 9 — 6 months, dose 2
Symptoms: Pregnant
Release 10 — 12 months, dose 2
Symptoms: Pregnant
Release 11 — 3 months, dose 3
Symptoms: Cold like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release